- The trend backdrop is active with a 5-week active streak.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
4169
TAI
Week ended 07 Aug 2026
Weekly Investor Report
TCM Biotech International Corp. · Healthcare · Biotechnology
Latest close
157.0 TWD
-4.8%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is -14.4% below the Trend Line and sits at 37.1% of its 52-week range. The latest completed week returned -4.8%, after a -41.8% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
27
out of 100
Latest Close
157.0 TWD
7 Aug 2026
1W Return
-4.8%
latest completed week
4W Return
-41.8%
short-term follow-through
12W Return
5.9%
quarterly tape
Trend Breadth
76.9%
40 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- Price is below the Trend Line, which keeps downside pressure in focus.
- Next-week expectancy is negative at 40.96% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-4.8%
Latest completed week; four-week move -41.8%.
Indicator stack
60/61
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.96%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is -14.4% below the Trend Line and sits at 37.1% of its 52-week range. The latest completed week returned -4.8%, after a -41.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5312-week average 0.34
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.53Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -41.8% over four weeks, 5.9% over 12 weeks, and 116.4% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year40
Trend breadth76.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.60Latest activity-pressure read.
Pressure change8.0%Four-week change in activity pressure.
Leadership-29.18Latest relative-leadership reading.
RS change-231.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-45.9%Distance below the 52-week high.
13-week volatility13.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+21.6%Week of 10 Jul.
Worst week-33.3%Week of 31 Jul.
Latest week-4.8%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains1
Flat weeks0
Modest losses8
Sharp losses8
Recent vol13.2%13-week weekly-return volatility.
Base vol10.4%52-week weekly-return volatility.
Up/down split22/29Count of positive and negative weeks in the 52-week window.
Average skew11.3% / -4.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank55 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank19 / 19
Group average-6.3%
Trend breadth31.6%
Trend31.6%active weekly trend signals
MD47.4%positive activity pressure
RS10.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape33/100
Trend, activity pressure, participation, and risk combine to a 33/100 tape read.
Indicator analysis42/100Latest 12-week confirmation: trend 5/12, activity pressure 5/12, relative leadership 3/12.
Activity pressure 0.53; No reversal markers Next-Week ExpectancyNegative 40.96%Next-week expectancy is negative with a 40.96% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 157.0 TWD | -4.8% | 183.3 TWD | 93.35 TWD | 0.60 | -29.18 | 853.4K | On |
| 31 Jul 2026 | 165.0 TWD | -33.3% | 183.9 TWD | 92.73 TWD | 1.05 | -23.53 | 2.9M | On |
| 24 Jul 2026 | 247.5 TWD | -1.7% | 184.2 TWD | 92.08 TWD | 1.25 | 13.70 | 1.3M | On |
| 17 Jul 2026 | 251.7 TWD | -6.7% | 181.7 TWD | 90.91 TWD | 1.16 | 19.69 | 2.0M | On |
| 10 Jul 2026 | 269.7 TWD | 21.6% | 178.7 TWD | 89.70 TWD | 0.55 | 22.25 | 4.5M | On |
| 3 Jul 2026 | 221.7 TWD | 15.6% | 175.6 TWD | 88.40 TWD | -0.21 | -1.23 | 2.4M | Off |
| 26 Jun 2026 | 191.8 TWD | 14.3% | 174.3 TWD | 87.33 TWD | -0.86 | -9.52 | 2.5M | Off |
| 19 Jun 2026 | 167.8 TWD | 9.4% | 174.1 TWD | 86.45 TWD | -1.38 | -23.48 | 705.0K | Off |
| 12 Jun 2026 | 153.3 TWD | -0.3% | 174.5 TWD | 85.72 TWD | -1.43 | -26.10 | 554.1K | Off |
| 5 Jun 2026 | 153.8 TWD | -1.9% | 175.5 TWD | 85.10 TWD | -1.48 | -27.08 | 818.3K | Off |
| 29 May 2026 | 156.8 TWD | -1.3% | 175.6 TWD | 84.49 TWD | -1.51 | -24.87 | 679.7K | Off |
| 22 May 2026 | 158.8 TWD | 7.1% | 175.9 TWD | 83.81 TWD | -1.56 | -19.07 | 702.6K | Off |
| 15 May 2026 | 148.3 TWD | -4.8% | 175.3 TWD | 83.11 TWD | -1.52 | -21.94 | 654.0K | Off |
| 8 May 2026 | 155.8 TWD | -3.4% | 174.5 TWD | 82.48 TWD | -1.39 | -18.45 | 959.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.